1. Home
  2. BLTE vs SEB Comparison

BLTE vs SEB Comparison

Compare BLTE & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$146.23

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Seaboard Corporation

SEB

Seaboard Corporation

HOLD

Current Price

$4,874.00

Market Cap

5.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
SEB
Founded
2018
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.0B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
BLTE
SEB
Price
$146.23
$4,874.00
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$198.00
N/A
AVG Volume (30 Days)
215.5K
9.2K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
0.17%
EPS Growth
N/A
467.71
EPS
N/A
124.24
Revenue
N/A
$5,809,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$492.11
N/A
P/E Ratio
N/A
$40.78
Revenue Growth
N/A
7.99
52 Week Low
$56.68
$2,740.00
52 Week High
$200.00
$5,989.37

Technical Indicators

Market Signals
Indicator
BLTE
SEB
Relative Strength Index (RSI) 51.55 40.33
Support Level $130.00 $4,752.09
Resistance Level $168.44 $5,183.91
Average True Range (ATR) 8.61 243.65
MACD 1.00 -10.55
Stochastic Oscillator 75.20 3.53

Price Performance

Historical Comparison
BLTE
SEB

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

Share on Social Networks: